Company / FCF Margin
Praxis Precision Medicines, Inc. FCF Margin History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1540.5%
FY2024
5-year range
-4543.8% / -1540.5%
FY2023-FY2024
Trend
+66.1%
vs FY2023
Sector context
#125 of 134
Health Care
What the data says
Among 134 Health Care companies, Praxis Precision Medicines, Inc. is in the bottom 7% for fcf margin.
Based on SEC 10-K filings.
-1540.5% in FY2024.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 134This company -1540.5% Sector average -637.8%
▼
-141.5% below sector average
Key checks
Key Insights
- In FY2024, fcf margin increased 66.1% year-over-year.
- Currently 902.7pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -1540.5% | +66.1% |
| FY2023 | -4543.8% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026